Your session is about to expire
← Back to Search
Vision Training for Low Vision (FLAP Trial)
FLAP Trial Summary
This trial looks at how different types of training and therapy can help people with low vision. The findings could help millions of people who suffer from this condition.
FLAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFLAP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FLAP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 30 years old.You weigh more than 300 pounds.You have very old or bright tattoos, especially near your head.I am hearing-impaired.You are afraid of being in small, enclosed spaces.You have braces or a permanent retainer.You have a pacemaker or any metal in your body that can be affected by a magnetic field.My body's widest part measures over 60 inches.I experience hallucinations or delusions.You require special glasses for clear distance vision, except for the simple MR-compatible glasses that can be provided.You have had a severe head injury in the past.You have good vision (20/40 or better).I have no history of eye diseases affecting the retina.
- Group 1: Condition 2: Training spatial integration
- Group 2: Condition 3: Training spatial attention
- Group 3: Condition 1: Training visual sensitivity
- Group 4: Condition 4: Combination training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age restriction for this research limited to those below 70 years old?
"The parameters for entry into this clinical trial require that participants are between 18 and 30 years of age."
Are recruitment efforts ongoing for this clinical experiment?
"Yes, the clinical trial is still ongoing. According to information shared on clinicaltrials.gov this trial was initiated on October 24th 2022 and underwent its latest revision of data on October 31st 2022."
Are there specific criteria for qualifying to join this clinical experiment?
"To join this clinical trial, potential participants must have macular degeneration and be under 30 years of age. Currently, the research team is looking to enrol a cohort of 120 individuals."
What is the overall number of participants in this clinical experiment?
"Affirmative. According to clinicaltrials.gov, this medical experiment is open for recruitment and was initially posted on October 24th 2022 with the latest edit being made on October 31st 2022. The trial necessitates 120 participants from a single research centre."
Share this study with friends
Copy Link
Messenger